Jeff Yass’s Alexza Pharmaceuticals Inc ALXA Stock Holding History

Jeff Yass’s Portfolio ALXA Stock Details ALXA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-35,000	Closed	-$52K	–	10403
2014 Q4	$52K	Sell	35,000 -11,500	-25%	-$20.5K	﹤0.01%	9361
2014 Q3	$108K	Buy	46,500 +6,700	+17%	+$25.6K	﹤0.01%	9046
2014 Q2	$182K	Sell	39,800 -53,900	-58%	-$233K	﹤0.01%	9142
2014 Q1	$415K	Buy	93,700 +55,600	+146%	+$285K	﹤0.01%	7045
2013 Q4	$180K	Sell	38,100 -97,100	-72%	-$476K	﹤0.01%	8347
2013 Q3	$692K	Buy	135,200 +53,300	+65%	+$251K	﹤0.01%	5932
2013 Q2	$355K	Buy	+81,900	New	+$371K	﹤0.01%	6549

Jeff Yass's ALXA Position: Q2 2016 in Review

Jeff Yass sold out of Alexza Pharmaceuticals Inc (ALXA) in Q2 2016, closing a stake of 26,110 shares — an estimated $13K sold.

Jeff Yass first reported a position in ALXA in Q4 2013 and held it in 6 quarters. The position peaked at $115K in Q4 2013. 0 funds tracked by Wall St. Rank hold ALXA as of Q2 2016.

Jeff Yass reported no remaining Alexza Pharmaceuticals Inc position as of Q2 2016 after selling out during the quarter.
Jeff Yass sold 26,110 Alexza Pharmaceuticals Inc shares in Q2 2016, an estimated $13K.
Jeff Yass first reported a position in Alexza Pharmaceuticals Inc in Q4 2013 and held it in 6 quarters.
Jeff Yass's Alexza Pharmaceuticals Inc position peaked at $115K in Q4 2013.
0 funds tracked by Wall St. Rank held Alexza Pharmaceuticals Inc as of Q2 2016.

Based on Susquehanna International Group's 13F filing for Q2 2016, filed 15 Aug 2016.